Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.65B |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$6.34B |
| 3 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.28B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.36B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.04B |
Top Sells
| 1 |
Texas Instruments
TXN
|
+$387M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$272M |
| 4 |
Medtronic
MDT
|
+$249M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| 1 | Technology | 21.37% |
| 2 | Financials | 10.65% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Fortrea Holdings
FTRE
$917M
| $13.1M | ﹤0.01% |
561,143
-5,866
| -1% | -$137K |
|
1902
Golar LNG
GLNG
$4.16B
| $13.1M | ﹤0.01% |
417,613
-42,362
| -9% | -$1.33M |
|
1903
Nu Skin
NUS
$596M
| $13.1M | ﹤0.01% |
1,241,988
-147,217
| -11% | -$1.55M |
|
|
AHH
1904
Armada Hoffler Properties
AHH
$596M
| $13.1M | ﹤0.01% |
1,180,313
-362,691
| -24% | -$4.02M |
|
1905
Ligand Pharmaceuticals
LGND
$3.23B
| $13.1M | ﹤0.01% |
155,340
+5,564
| +4% | +$469K |
|
1906
PAR Technology
PAR
$1.79B
| $13.1M | ﹤0.01% |
277,256
+57,203
| +26% | +$2.69M |
|
1907
Akero Therapeutics
AKRO
$3.48B
| $13M | ﹤0.01% |
554,865
+36,579
| +7% | +$858K |
|
1908
Nurix Therapeutics
NRIX
$691M
| $13M | ﹤0.01% |
623,404
-18,786
| -3% | -$392K |
|
1909
Coupang
CPNG
$59.1B
| $13M | ﹤0.01% |
620,870
+165,859
| +36% | +$3.47M |
|
1910
Enviri
NVRI
$983M
| $13M | ﹤0.01% |
1,503,785
-215,970
| -13% | -$1.86M |
|
1911
Gulfport Energy Corp
GPOR
$3.06B
| $13M | ﹤0.01% |
85,885
+6,080
| +8% | +$918K |
|
1912
AMC Networks
AMCX
$357M
| $12.9M | ﹤0.01% |
1,336,197
-271,607
| -17% | -$2.62M |
|
1913
Teekay Tankers
TNK
$1.8B
| $12.9M | ﹤0.01% |
186,999
-8,140
| -4% | -$560K |
|
1914
Berkshire Hathaway Class A
BRK.A
$1.06T
| $12.9M | ﹤0.01% |
21
-65
| -76% | -$39.8M |
|
1915
Columbus McKinnon
CMCO
$415M
| $12.8M | ﹤0.01% |
371,943
+8,330
| +2% | +$288K |
|
|
NXRT
1916
NexPoint Residential Trust
NXRT
$858M
| $12.8M | ﹤0.01% |
323,885
+10,544
| +3% | +$417K |
|
1917
Dynavax Technologies
DVAX
$1.1B
| $12.8M | ﹤0.01% |
1,137,573
+58,702
| +5% | +$659K |
|
1918
American Healthcare REIT
AHR
$7.19B
| $12.8M | ﹤0.01% |
873,621
+551,653
| +171% | +$8.06M |
|
1919
Array Technologies
ARRY
$1.17B
| $12.7M | ﹤0.01% |
1,240,390
+17,265
| +1% | +$177K |
|
1920
Vera Therapeutics
VERA
$1.52B
| $12.7M | ﹤0.01% |
351,088
+12,663
| +4% | +$458K |
|
1921
VSE Corp
VSEC
$3.4B
| $12.6M | ﹤0.01% |
143,196
+24,206
| +20% | +$2.14M |
|
1922
KE Holdings
BEKE
$23.7B
| $12.6M | ﹤0.01% |
890,795
+101,610
| +13% | +$1.44M |
|
1923
Kura Oncology
KURA
$711M
| $12.6M | ﹤0.01% |
610,846
+12,122
| +2% | +$250K |
|
1924
Payoneer
PAYO
$2.34B
| $12.6M | ﹤0.01% |
2,269,901
+148,155
| +7% | +$821K |
|
1925
Ryerson Holding
RYI
$723M
| $12.6M | ﹤0.01% |
644,200
+164,039
| +34% | +$3.2M |
|